Research Assistant in Cellular Immunotherapy

Research Assistant in Cellular Immunotherapy The post sits in the Cellular Therapy group within the Research Department of Haematology, whose major focus is the engineering of T cells for therapeutic application. The group runs an integrated discovery-to-clinic programme, taking novel chimeric antigen receptor (CAR) designs from molecular cloning through in vitro and in vivo testing and into first-in-human trials, including the FRACTALL trial of anti-CCR9 CAR-T cells in T cell acute lymphoblastic leukaemia (T-ALL), which is open and dosing patients. This post is funded by the Medical Research Council (grant 572202, anti-CCR9 CAR-T cells) and is available until 16 July 2028 in the first instance. The post is full time and available from 1 November 2026, or as soon as possible thereafter. Applications must include a CV and a cover letter.